Drug Trial Radar · NCT07758660
Alzheimer's Disease Research Center (ADRC) PET Component Study
Last checked: Nov 20, 2026Latest source record: Aug 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
120
Planned (sponsor's estimate)
Start
Aug 6, 2026
Primary completion
May 31, 2031
Study completion May 31, 2033
Sponsor
- Lead sponsor
- Patrick LaoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute on Aging (NIA)
- First posted
- Aug 11, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to further engage and characterize Alzheimer's Disease Research Center (ADRC) participants through additional research opportunities, particularly PET imaging. Amyloid and Tau PET imaging will be collected in 24 participants per year, for a total of 120 participants over five years. All participants will be followed longitudinally, including through potential transitions from normal aging to mild cognitive impairment (MCI) and Alzheimer's disease and related dementias (ADRD).
Conditions
- Alzheimer Disease
- Mild Cognitive Impairment (MCI)
- Dementia
Interventions
18F-MK6240Drug
MK-6240 is experimental but has been used in several human studies before and has been proven to accurately measure tau in the brain.
18F-Florbetaben (FBB)Drug
Florbetaben has been approved by the FDA to help diagnose Alzheimer's disease. Florbetaben measures amyloid in the brain.
Primary outcomes
What the sponsor says the trial is designed to measure.
- 18F-FBB Standardized Uptake Value RatioTime frame: Up to 12 months
- 18F-MK6240 Standardized Uptake Value RatioTime frame: Up to 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Columbia University Irving Medical Center
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.